Many U.S. Adults Lost Trust in Physicians, Hospitals During Pandemic
Medically reviewed by Drugs.com.
By Lori Solomon HealthDay Reporter
TUESDAY, Aug. 6, 2024 -- U.S. adults lost trust in physicians and hospitals during the COVID-19 pandemic, according to a study published online July 31 in JAMA Network Open.
Roy H. Perlis, M.D., from Massachusetts General Hospital in Boston, and colleagues examined how trust in physicians and hospitals changed during the COVID-19 pandemic. The analysis included survey results from 582,634 responses across 24 survey waves (443,455 unique respondents).
The researchers found that overall, the proportion of adults reporting a lot of trust for physicians and hospitals decreased from 71.5 percent in April 2020 to 40.1 percent in January 2024. Factors associated with lower trust in spring and summer 2023 included ages 25 to 64 years, female gender, lower educational level, lower income, Black race, and living in a rural setting. Even when controlling for partisanship, results persisted. Greater trust was associated with greater likelihood of vaccination for SARS-CoV-2 (adjusted odds ratio, 4.94) or influenza (adjusted odds ratio, 5.09) and receiving a SARS-CoV-2 booster (adjusted odds ratio, 3.62).
"As lower levels of trust were associated with lesser likelihood of pursuing vaccination, restoring trust may represent a public health imperative," the authors write.
One author disclosed providing consulting services for pharmaceutical and biotechnology industries.
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
Source: HealthDay
Posted : 2024-08-07 23:15
Read more
- Elevar Therapeutics Announces FDA Acceptance of New Drug Application Resubmission for Rivoceranib in Combination with Camrelizumab as a First-line Systemic Treatment for Unresectable Hepatocellular Carcinoma
- Quitting Smoking After Cancer Diagnosis Boosts Survival by Up to 26%
- Medicaid Covers GLP-1 Meds for Obesity in Just 13 States
- One in Six Emergency Departments Have High Pediatric Readiness
- Preventing, Treating Sports Injuries in Kids: A Guide
- NIH Trial of Rectal Microbicide for HIV Prevention Begins in the United States
Disclaimer
Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.
The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Popular Keywords
- metformin obat apa
- alahan panjang
- glimepiride obat apa
- takikardia adalah
- erau ernie
- pradiabetes
- besar88
- atrofi adalah
- kutu anjing
- trakeostomi
- mayzent pi
- enbrel auto injector not working
- enbrel interactions
- lenvima life expectancy
- leqvio pi
- what is lenvima
- lenvima pi
- empagliflozin-linagliptin
- encourage foundation for enbrel
- qulipta drug interactions